Natural history, with clinical, biochemical, and molecular characterization of classical homocystinuria in the Qatari population
Nader Al‐Dewik(St George's, University of London), Tawfeg Ben‐Omran(Qatar Airways (Qatar)), Gheyath K. Nasrallah(Qatar University), Mariam Al‐Mureikhi(Hamad Medical Corporation), Henk J. Blom(Erasmus MC), Hilal Al Rifai(University of London), Beat Thöny(University of Zurich), Reem Al Saadi(Hamad Medical Corporation), Johannes Häberle(University Children's Hospital Zurich), Fatma Al‐Mesaifri(Hamad Medical Corporation), Yassmin Mahmoud(Hamad Medical Corporation), Muthanna Samara(Kingston University), Karen El‐Akouri(Hamad Medical Corporation), Noora Shahbeck(Hamad Medical Corporation), Mariam AlMulla(Hamad Medical Corporation), Warren D. Kruger(Fox Chase Cancer Center), Ghassan Abdoh(Hamad Medical Corporation), Alaa Ali(Hamad Medical Corporation), Laila Mahmoud(Hamad Medical Corporation), Rehab Ali(Hamad Medical Corporation), Sara Musa(Hamad Medical Corporation)
Cited by 22
Related Papers
Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis
|New England Journal of Medicine|1996|1.1k
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
|Neuromuscular Disorders|2019|636
Suggested guidelines for the diagnosis and management of urea cycle disorders
|Orphanet Journal of Rare Diseases|2012|627